# Applied Optoelectronics, Inc.: financial statements, quarterly

AAOI · Nasdaq · CIK 1158114 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aaoi.md) · [Financials](/companies/aaoi/financials.md) · [Filings](/companies/aaoi/filings.md) · [Insiders](/companies/aaoi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aaoi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.5](/filings/0001437749-24-033913.md) | [60.5 d](/filings/0001437749-26-005875.md) | [40.7](/filings/0001437749-25-015518.md) | [43.3](/filings/0001437749-25-025450.md) | [65.2](/filings/0001437749-25-033627.md) | [100 d](/filings/0001437749-26-005875.md) | [99.9](/filings/0001437749-26-015620.md) | [103](/filings/0001437749-26-026278.md) | [119](/filings/0001437749-25-033627.md) | [134 d](/filings/0001437749-26-005875.md) | [151](/filings/0001437749-26-015620.md) | [192](/filings/0001437749-26-026278.md) |
| Cost of revenue | $m | [42.4](/filings/0001437749-24-033913.md) | [38.8 d](/filings/0001437749-26-005875.md) | [33.1](/filings/0001437749-25-015518.md) | [33.7](/filings/0001437749-25-025450.md) | [49.2](/filings/0001437749-25-033627.md) | [71.5 d](/filings/0001437749-26-005875.md) | [69.3](/filings/0001437749-26-015620.md) | [71.8](/filings/0001437749-26-026278.md) | [85.4](/filings/0001437749-25-033627.md) | [92.3 d](/filings/0001437749-26-005875.md) | [107](/filings/0001437749-26-015620.md) | [139](/filings/0001437749-26-026278.md) |
| Gross profit | $m | [20.2](/filings/0001437749-24-033913.md) | [21.6 d](/filings/0001437749-26-005875.md) | [7.6](/filings/0001437749-25-015518.md) | [9.6](/filings/0001437749-25-025450.md) | [15.9](/filings/0001437749-25-033627.md) | [28.7 d](/filings/0001437749-26-005875.md) | [30.5](/filings/0001437749-26-015620.md) | [31.2](/filings/0001437749-26-026278.md) | [33.3](/filings/0001437749-25-033627.md) | [41.9 d](/filings/0001437749-26-005875.md) | [43.9](/filings/0001437749-26-015620.md) | [53.2](/filings/0001437749-26-026278.md) |
| Research and development | $m | [9.5](/filings/0001437749-24-033913.md) | [9.3 d](/filings/0001437749-26-005875.md) | [11.7](/filings/0001437749-25-015518.md) | [13.1](/filings/0001437749-25-025450.md) | [13.4](/filings/0001437749-25-033627.md) | [16.7 d](/filings/0001437749-26-005875.md) | [17.8](/filings/0001437749-26-015620.md) | [20.6](/filings/0001437749-26-026278.md) | [21.3](/filings/0001437749-25-033627.md) | [25.8 d](/filings/0001437749-26-005875.md) | [25.7](/filings/0001437749-26-015620.md) | [34.9](/filings/0001437749-26-026278.md) |
| Operating income | $m | [(6.7)](/filings/0001437749-24-033913.md) | [(4.5) d](/filings/0001437749-26-005875.md) | [(21.6)](/filings/0001437749-25-015518.md) | [(26.2)](/filings/0001437749-25-025450.md) | [(16.5)](/filings/0001437749-25-033627.md) | [(6.5) d](/filings/0001437749-26-005875.md) | [(8.9)](/filings/0001437749-26-015620.md) | [(16.0)](/filings/0001437749-26-026278.md) | [(18.2)](/filings/0001437749-25-033627.md) | [(11.5) d](/filings/0001437749-26-005875.md) | [(13.0)](/filings/0001437749-26-015620.md) | [(24.7)](/filings/0001437749-26-026278.md) |
| Interest expense | $m | [2.0](/filings/0001437749-23-031255.md) | [3.1 d](/filings/0001437749-24-005367.md) | [1.7](/filings/0001437749-25-015518.md) | [1.7](/filings/0001437749-25-025450.md) | [1.7](/filings/0001437749-25-033627.md) | [1.8 d](/filings/0001437749-26-005875.md) | [0.9](/filings/0001437749-26-015620.md) | [0.8](/filings/0001437749-26-026278.md) | [0.9](/filings/0001437749-25-033627.md) | [0.8 d](/filings/0001437749-26-005875.md) | [0.9](/filings/0001437749-26-015620.md) | [0.9](/filings/0001437749-26-026278.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-033913.md) | [0.0 d](/filings/0001437749-26-005875.md) | [0.0](/filings/0001437749-25-015518.md) | [0.0](/filings/0001437749-25-025450.md) | [0.0](/filings/0001437749-25-033627.md) | [0.0 d](/filings/0001437749-26-005875.md) | [0.0](/filings/0001437749-26-015620.md) | [0.0](/filings/0001437749-26-026278.md) | [0.0](/filings/0001437749-25-033627.md) | [(8.5) d](/filings/0001437749-26-005875.md) | [1.0](/filings/0001437749-26-015620.md) | [1.3](/filings/0001437749-26-026278.md) |
| Net income | $m | [(9.0)](/filings/0001437749-24-033913.md) | [(13.9) d](/filings/0001437749-26-005875.md) | [(23.2)](/filings/0001437749-25-015518.md) | [(26.1)](/filings/0001437749-25-025450.md) | [(17.8)](/filings/0001437749-25-033627.md) | [(120) d](/filings/0001437749-26-005875.md) | [(9.2)](/filings/0001437749-26-015620.md) | [(9.1)](/filings/0001437749-26-026278.md) | [(17.9)](/filings/0001437749-25-033627.md) | [(2.0) d](/filings/0001437749-26-005875.md) | [(14.3)](/filings/0001437749-26-015620.md) | [(22.8)](/filings/0001437749-26-026278.md) |
| Diluted EPS | $ per share | [(0.27)](/filings/0001437749-24-033913.md) | not reported | [(0.60)](/filings/0001437749-25-015518.md) | [(0.66)](/filings/0001437749-25-025450.md) | [(0.42)](/filings/0001437749-25-033627.md) | not reported | [(0.18)](/filings/0001437749-26-015620.md) | [(0.16)](/filings/0001437749-26-026278.md) | [(0.28)](/filings/0001437749-25-033627.md) | not reported | [(0.19)](/filings/0001437749-26-015620.md) | [(0.28)](/filings/0001437749-26-026278.md) |
| Basic EPS | $ per share | [(0.27)](/filings/0001437749-24-033913.md) | not reported | [(0.60)](/filings/0001437749-25-015518.md) | [(0.66)](/filings/0001437749-25-025450.md) | [(0.42)](/filings/0001437749-25-033627.md) | not reported | [(0.18)](/filings/0001437749-26-015620.md) | [(0.16)](/filings/0001437749-26-026278.md) | [(0.28)](/filings/0001437749-25-033627.md) | not reported | [(0.19)](/filings/0001437749-26-015620.md) | [(0.28)](/filings/0001437749-26-026278.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [21.9](/filings/0001437749-23-031255.md) | [45.4](/filings/0001437749-25-005575.md) | [8.4](/filings/0001437749-24-015696.md) | [10.7](/filings/0001437749-24-024888.md) | [34.1](/filings/0001437749-24-033913.md) | [67.4](/filings/0001437749-26-005875.md) | [51.1](/filings/0001437749-25-015518.md) | [64.7](/filings/0001437749-25-025450.md) | [137](/filings/0001437749-25-033627.md) | [206](/filings/0001437749-26-026278.md) | [440](/filings/0001437749-26-015620.md) | [500](/filings/0001437749-26-026278.md) |
| Current assets | $m | [164](/filings/0001437749-23-031255.md) | [173](/filings/0001437749-25-005575.md) | [134](/filings/0001437749-24-015696.md) | [133](/filings/0001437749-24-024888.md) | [188](/filings/0001437749-24-033913.md) | [301](/filings/0001437749-26-005875.md) | [359](/filings/0001437749-25-015518.md) | [458](/filings/0001437749-25-025450.md) | [575](/filings/0001437749-25-033627.md) | [676](/filings/0001437749-26-026278.md) | [993](/filings/0001437749-26-015620.md) | [1,190](/filings/0001437749-26-026278.md) |
| Total assets | $m | [374](/filings/0001437749-23-031255.md) | [389](/filings/0001437749-25-005575.md) | [351](/filings/0001437749-24-015696.md) | [348](/filings/0001437749-24-024888.md) | [410](/filings/0001437749-24-033913.md) | [547](/filings/0001437749-26-005875.md) | [645](/filings/0001437749-25-015518.md) | [797](/filings/0001437749-25-025450.md) | [979](/filings/0001437749-25-033627.md) | [1,168](/filings/0001437749-26-026278.md) | [1,566](/filings/0001437749-26-015620.md) | [2,301](/filings/0001437749-26-026278.md) |
| Current liabilities | $m | [188](/filings/0001437749-23-031255.md) | [93.4](/filings/0001437749-25-005575.md) | [74.6](/filings/0001437749-24-015696.md) | [80.9](/filings/0001437749-24-024888.md) | [117](/filings/0001437749-24-033913.md) | [170](/filings/0001437749-26-005875.md) | [191](/filings/0001437749-25-015518.md) | [217](/filings/0001437749-25-025450.md) | [249](/filings/0001437749-25-033627.md) | [257](/filings/0001437749-26-026278.md) | [259](/filings/0001437749-26-015620.md) | [428](/filings/0001437749-26-026278.md) |
| Total liabilities | $m | [195](/filings/0001437749-23-031255.md) | [174](/filings/0001437749-25-005575.md) | [155](/filings/0001437749-24-015696.md) | [162](/filings/0001437749-24-024888.md) | [198](/filings/0001437749-24-033913.md) | [318](/filings/0001437749-26-005875.md) | [336](/filings/0001437749-25-015518.md) | [372](/filings/0001437749-25-025450.md) | [419](/filings/0001437749-25-033627.md) | [435](/filings/0001437749-26-026278.md) | [460](/filings/0001437749-26-015620.md) | [633](/filings/0001437749-26-026278.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-23-031255.md) | [0.0](/filings/0001437749-25-005575.md) | [4.3](/filings/0001437749-25-015518.md) | [0.0](/filings/0001437749-24-024888.md) | [0.0](/filings/0001437749-24-033913.md) | [4.3](/filings/0001437749-26-005875.md) | [1.8](/filings/0001437749-25-015518.md) | [0.0](/filings/0001437749-25-025450.md) | [0.0](/filings/0001437749-25-033627.md) | [0.0](/filings/0001437749-26-026278.md) | [0.0](/filings/0001437749-26-015620.md) | [1.7](/filings/0001437749-26-026278.md) |
| Current portion of debt | $m | [31.3](/filings/0001437749-23-031255.md) | [23.2](/filings/0001437749-25-005575.md) | [22.4](/filings/0001437749-25-015518.md) | [22.5](/filings/0001437749-24-024888.md) | [29.5](/filings/0001437749-24-033913.md) | [22.4](/filings/0001437749-26-005875.md) | [20.3](/filings/0001437749-25-015518.md) | [22.2](/filings/0001437749-25-025450.md) | [28.0](/filings/0001437749-25-033627.md) | [34.0](/filings/0001437749-26-026278.md) | [41.2](/filings/0001437749-26-015620.md) | [57.3](/filings/0001437749-26-026278.md) |
| Shareholders' equity | $m | [178](/filings/0001437749-24-033913.md) | [215](/filings/0001437749-26-005875.md) | [196](/filings/0001437749-25-025450.md) | [186](/filings/0001437749-25-033627.md) | [212](/filings/0001437749-25-033627.md) | [229](/filings/0001437749-26-026278.md) | [309](/filings/0001437749-26-026278.md) | [425](/filings/0001437749-26-026278.md) | [559](/filings/0001437749-25-033627.md) | [734](/filings/0001437749-26-026278.md) | [1,106](/filings/0001437749-26-026278.md) | [1,668](/filings/0001437749-26-026278.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(15.3) d](/filings/0001437749-24-033913.md) | [1.6 d](/filings/0001437749-26-005875.md) | [(28.5)](/filings/0001437749-25-015518.md) | [(2.0) d](/filings/0001437749-25-025450.md) | [(14.4) d](/filings/0001437749-25-033627.md) | [(24.6) d](/filings/0001437749-26-005875.md) | [(50.9)](/filings/0001437749-26-015620.md) | [(65.5) d](/filings/0001437749-26-026278.md) | [(28.5) d](/filings/0001437749-25-033627.md) | [(29.6) d](/filings/0001437749-26-005875.md) | [(85.4)](/filings/0001437749-26-015620.md) | [11.6 d](/filings/0001437749-26-026278.md) |
| Capital expenditure | $m | [1.5 d](/filings/0001437749-24-033913.md) | [6.2 d](/filings/0001437749-26-005875.md) | [5.8](/filings/0001437749-25-015518.md) | [3.0 d](/filings/0001437749-25-025450.md) | [6.3 d](/filings/0001437749-25-033627.md) | [28.4 d](/filings/0001437749-26-005875.md) | [28.4](/filings/0001437749-26-015620.md) | [25.5 d](/filings/0001437749-25-025450.md) | [50.2 d](/filings/0001437749-25-033627.md) | [75.0 d](/filings/0001437749-26-005875.md) | [58.2](/filings/0001437749-26-015620.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.8](/filings/0001437749-23-031255.md) | [28.9](/filings/0001437749-24-015696.md) | [29.5](/filings/0001437749-24-024888.md) | [32.8](/filings/0001437749-24-033913.md) | [38.4](/filings/0001437749-25-015518.md) | [39.4](/filings/0001437749-25-025450.md) | [42.3](/filings/0001437749-25-033627.md) | [50.0](/filings/0001437749-26-015620.md) | [56.8](/filings/0001437749-26-026278.md) | [63.3](/filings/0001437749-25-033627.md) | [76.0](/filings/0001437749-26-015620.md) | [81.6](/filings/0001437749-26-026278.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 84,569,237 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026278.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.